BACKGROUND: Evidence suggests a higher prevalence of type 2 diabetes (T2D) in The Netherlands than in England, although generalized obesity prevalence is substantially lower in The Netherlands. Metabolic syndrome (MS) is more strongly associated with the risk of progression to T2D than generalized obesity. Therefore examining MS may help to better understand the differences in T2D between the two countries. We assessed whether the Dutch and English differences in T2D prevalence reflect similar differences in MS in Whites, South-Asian Indians and African-Caribbeans living in these two countries. METHODS: Secondary analyses of population-based studies of 3010 participants aged 35-60 years. Metabolic syndrome was defined according to the International Diabetes Federation criteria. Prevalence ratios (PRs) were estimated using regression models. RESULTS: In general, the Dutch ethnic groups had a higher prevalence of MS than their English counterparts. Adjusted PRs were 1.37[95% confidence interval (CI)1.03-1.82] and 1.52 (1.06-2.19) in White-Dutch men and women compared to White-English men and women; 2.20 (1.14-4.26) and 1.46 (0.96-2.24) in Dutch-African-Caribbean men and women compared to English-African-Caribbean men and women and 0.97 (0.74-1.27) and 1.42 (1.00-2.03) in Dutch-Indian men and women compared with their English-Indian peers, respectively. Similar patterns were also observed for some MS components, e.g. raised fasting glucose in men and central obesity in women. CONCLUSION: The comparatively high prevalence of MS among Dutch ethnic groups may contribute to their high prevalence of T2D. The high levels of some MS components, e.g. raised fasting glucose in men and central obesity in women add to the high prevalence of MS in Dutch ethnic groups.
BACKGROUND: Evidence suggests a higher prevalence of type 2 diabetes (T2D) in The Netherlands than in England, although generalized obesity prevalence is substantially lower in The Netherlands. Metabolic syndrome (MS) is more strongly associated with the risk of progression to T2D than generalized obesity. Therefore examining MS may help to better understand the differences in T2D between the two countries. We assessed whether the Dutch and English differences in T2D prevalence reflect similar differences in MS in Whites, South-Asian Indians and African-Caribbeans living in these two countries. METHODS: Secondary analyses of population-based studies of 3010 participants aged 35-60 years. Metabolic syndrome was defined according to the International Diabetes Federation criteria. Prevalence ratios (PRs) were estimated using regression models. RESULTS: In general, the Dutch ethnic groups had a higher prevalence of MS than their English counterparts. Adjusted PRs were 1.37[95% confidence interval (CI)1.03-1.82] and 1.52 (1.06-2.19) in White-Dutch men and women compared to White-English men and women; 2.20 (1.14-4.26) and 1.46 (0.96-2.24) in Dutch-African-Caribbean men and women compared to English-African-Caribbean men and women and 0.97 (0.74-1.27) and 1.42 (1.00-2.03) in Dutch-Indian men and women compared with their English-Indian peers, respectively. Similar patterns were also observed for some MS components, e.g. raised fasting glucose in men and central obesity in women. CONCLUSION: The comparatively high prevalence of MS among Dutch ethnic groups may contribute to their high prevalence of T2D. The high levels of some MS components, e.g. raised fasting glucose in men and central obesity in women add to the high prevalence of MS in Dutch ethnic groups.
Authors: Jacob Spallek; Melina Arnold; Oliver Razum; Knud Juel; Grégoire Rey; Patrick Deboosere; Johan Pieter Mackenbach; Anton Eduard Kunst Journal: Eur J Epidemiol Date: 2012-11-20 Impact factor: 8.082
Authors: Charles Agyemang; Karlijn Meeks; Erik Beune; Ellis Owusu-Dabo; Frank P Mockenhaupt; Juliet Addo; Ama de Graft Aikins; Silver Bahendeka; Ina Danquah; Matthias B Schulze; Joachim Spranger; Tom Burr; Peter Agyei-Baffour; Stephen K Amoah; Cecilia Galbete; Peter Henneman; Kerstin Klipstein-Grobusch; Mary Nicolaou; Adebowale Adeyemo; Jan van Straalen; Liam Smeeth; Karien Stronks Journal: BMC Med Date: 2016-10-21 Impact factor: 8.775
Authors: Wilco Perini; Marieke B Snijder; Charles Agyemang; Ron Jg Peters; Anton E Kunst; Irene Gm van Valkengoed Journal: Eur J Prev Cardiol Date: 2019-07-25 Impact factor: 7.804
Authors: Eva L van der Linden; Karlijn Meeks; Erik Beune; Ama de-Graft Aikins; Juliet Addo; Ellis Owusu-Dabo; Frank P Mockenhaupt; Silver Bahendeka; Ina Danquah; Matthias B Schulze; Joachim Spranger; Kerstin Klipstein-Grobusch; Lambert Tetteh Appiah; Liam Smeeth; Karien Stronks; Charles Agyemang Journal: Eur J Public Health Date: 2019-10-01 Impact factor: 3.367
Authors: Karlijn A C Meeks; Karien Stronks; Adebowale Adeyemo; Juliet Addo; Silver Bahendeka; Erik Beune; Ellis Owusu-Dabo; Ina Danquah; Cecilia Galbete; Peter Henneman; Kerstin Klipstein-Grobusch; Frank P Mockenhaupt; Kwame Osei; Matthias B Schulze; Joachim Spranger; Liam Smeeth; Charles Agyemang Journal: Diabetologia Date: 2017-01-31 Impact factor: 10.122
Authors: Xuzhen Qin; Ling Qiu; Guodong Tang; Man-Fung Tsoi; Tao Xu; Lin Zhang; Zhihong Qi; Guangjin Zhu; Bernard M Y Cheung Journal: BMC Public Health Date: 2020-03-06 Impact factor: 3.295